Anestésico: Un agente que causa insensibilidad al dolor.

Demencia: Une estado de función mental deteriorada.

Dopamina: Un neurotransmisor presente en regiones del cerebro que regulan el movimiento, las emociones, la motivación, y la sensación de placer.

Epidemiología: La suma de los factores que controlan la presencia o ausencia de una enfermedad o afección.

Síndrome de abstinencia ("withdrawal"): Una variedad de síntomas que ocurren después de que se reduce o se para el uso de una droga adictiva.

Sistema nervioso central: El cerebro y la médula espinal.

Tóxico: Que causa efectos temporales o permanentes que son dañinos al funcionamiento de un órgano o de un grupo de órganos del cuerpo.

Referencias

Balster, R.L. Neural basis of inhalant abuse. Drug and Alcohol Dependence 51(1-2):207-214, 1998.

Bowen, S.E.; Wiley, J.L.; Evans, E.B.; Tokarz, M.E.; and Balster, R.L. Functional observational battery comparing effects of ethanol, 1,1,1-trichlorethane, ether, and flurothyl. Neurotoxicology and Teratology 18(5):577-585, 1996.

Edwards, R.W., and Oetting, E.R. Inhalant use in the United States. In: Kozel, N.; Sloboda, Z.; and De La Rosa, M. (eds.), Epidemiology of Inhalant Abuse: An International Perspective. National Institute on Drug Abuse Research Monograph 148. DHHS Publication No. NIH 95-3831. Washington, DC: U.S. Government Printing Office, 8-28, 1995.

Fendrich, M.; Mackesy-Amiti, M.E.; Wislar, J.S.; and Goldstein, P.J. Childhood abuse and the use of inhalants: Differences by degree of use. American Journal of Public Health 87(5):765-769, 1997.

Jones, H.E., and Balster, R.L. Inhalant abuse in pregnancy. Obstetrics and Gynecology Clinics of North America 25(1):153-167, 1998.

National Institute on Drug Abuse. National Survey Results on Drug Use From the Monitoring the Future Study, 2004 (www.monitoringthefuture.org).

National Institute on Drug Abuse. NIDA InfoFacts, Inhalants, 2004.

PRIDE Surveys National Summary for Grades 4 thru 6, 2002-2003.

Riegel, A.C., and French, E.D. Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride. Pharmacology, Biochemistry and Behavior 62(3):399-402, 1999.

Sharp, C.W., and Rosenberg, N.L. Inhalants. In: Lowinson, J.H.; Ruiz, P.; Millman, R.B.; and Langrod, J.G. (eds.), Substance Abuse: A Comprehensive Textbook, 3d. ed. Baltimore: Williams and Wilkins, 246-264, 1996.

Sharp, C.W., and Rosenberg, N. Inhalant-related disorders. In: Tasman, A.; Kay, J.; and Lieberman, J.A. (eds.), Psychiatry, Vol. 1. Philadelphia: W.B. Saunders, 835-852, 1997.

Substance Abuse and Mental Health Services Administration. National Findings From the 2002 National Survey on Drug Use and Health. SAMHSA, 2002.

Soderberg, L.S. Immunomodulation by nitrite inhalants may predispose abusers to AIDS and Kaposi's sarcoma. Journal of Neuroimmunology 83(1-2):157-161, 1998.

Soderberg, L.S. Increased tumor growth in mice exposed to inhaled isobutyl nitrite. Toxicology Letters 101(1-2):35-41, 1999.

Woody, G.E.; Donnell, D,; Seage, G.R.; et al. Non-injection substance use correlates with risky sex among men having sex with men: Data from HIV/NET. Drug and Alcohol Dependence 53(3):197-205, 1999; 279(6): 22-26, 1998.